WHO Unveils Strategy to Enhance Global Access to Childhood Cancer Medicines

The World Health Organization (WHO) and its partners have launched a new strategy to strengthen the global market for essential childhood cancer medicines. This initiative, titled 'Closing the childhood cancer survival gap through sustainable access to medicines: market shaping strategy 2026-2030,' aims to address limited access to quality-assured medicines in low- and middle-income countries. The goal is to improve survival rates for children with cancer worldwide by ensuring more consistent and equitable access to necessary treatments.